Research Service, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio.
Infect Control Hosp Epidemiol. 2014 Feb;35(2):139-43. doi: 10.1086/674857. Epub 2013 Dec 23.
To determine the source of a cluster of Klebsiella oxytoca isolates cultured from peritoneal fluid of 3 patients with cirrhosis on a single day.
Outbreak investigation and before-after study.
A Veterans Affairs medical center.
Epidemiologic investigation, analysis of antimicrobial susceptibility testing results and molecular typing of K. oxytoca isolates with repetitive sequence-based polymerase chain reaction (rep-PCR), review of microbiology laboratory procedures for processing peritoneal fluid cultures, and comparison of peritoneal fluid contamination rates 18 months before and after modification of laboratory procedures for culturing peritoneal fluid.
Each of the peritoneal fluid samples that grew K. oxytoca was inoculated into blood culture bottles by different clinicians at different hospital locations. None of the patients had clinical findings suggestive of peritonitis or elevated polymorphonuclear cell counts in peritoneal fluid (range, 3-25 cells/μL). Molecular typing with rep-PCR demonstrated that the K. oxytoca isolates were genetically related (greater than 95% similarity). Laboratory procedures included the routine addition of a culture medium supplement of yeast extract and dextrose from a multidose vial into blood culture bottles with peritoneal fluid. After discontinuing use of the culture medium supplement, there was a marked reduction in the number of peritoneal fluid cultures deemed as contaminants (14.3% vs 0.9%; [Formula: see text]).
A pseudo-outbreak of K. oxytoca peritonitis and high rates of contamination of peritoneal fluid were attributable to contamination of a multidose culture medium supplement. This article highlights the importance of discouraging the use of multidose vials in all clinical settings.
确定同一天从 3 例肝硬化患者的腹腔液中培养出的产酸克雷伯菌(Klebsiella oxytoca)分离株的聚集来源。
暴发调查和前后对照研究。
退伍军人事务部医疗中心。
进行流行病学调查,分析产酸克雷伯菌分离株的药敏试验结果和分子分型(采用重复序列基聚合酶链反应,rep-PCR),审查处理腹腔液培养的微生物学实验室程序,比较实验室程序修改前后腹腔液污染率 18 个月。
每个产酸克雷伯菌生长的腹腔液样本均由不同临床医生在不同医院地点接种到血培养瓶中。所有患者均无腹膜炎临床发现或腹腔液中中性粒细胞计数升高(范围 3-25 个/μL)。rep-PCR 分子分型表明产酸克雷伯菌分离株具有遗传相关性(相似度大于 95%)。实验室程序包括常规将酵母提取物和葡萄糖的多剂量小瓶培养液添加到含腹腔液的血培养瓶中。停止使用培养液补充剂后,腹腔液培养被认为是污染物的数量明显减少(14.3%比 0.9%;[公式:见正文])。
产酸克雷伯菌腹膜炎的假暴发和腹腔液高污染率归因于多剂量培养液补充剂的污染。本文强调了在所有临床环境中禁止使用多剂量小瓶的重要性。